Compare Heron Therapeutics Inc (HRTX) vs Stanley Black & Decker, Inc. (SWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Stanley Black & Decker, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Stanley Black & Decker, Inc. trades at $88.28 (market cap $13.60B). The key difference: Stanley Black & Decker, Inc. is far larger — about 148.7× Heron Therapeutics Inc's market cap, and Stanley Black & Decker, Inc. pays a 3.79% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | SWK | |
|---|---|---|
Market Cap | $91.46M | $13.60B |
Sector | Health | — |
52-Week High | $1.96 | $94.12 |
52-Week Low | $0.39 | $62.12 |
Enterprise Value | $189.36M | $19.77B |
Dividend Yield | — | 3.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
Stanley Black & Decker (SWK) trades at $87.52, down 2.94% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company has beaten earnings estimates for the last three quarters, with Q2 2026 results expected soon. Revenue has stabilized around $15.1B in 2025, while net income improved to $402M. The stock carries a P/E of 36.95 and a dividend yield supported by recent payouts.
SWK shows operational resilience with consistent cash flow and debt reduction, but faces headwinds in Tools & Outdoor demand. Analyst sentiment is mixed with a consensus hold rating; the stock offers value and momentum potential amid ongoing cost-saving initiatives and aerospace growth, though high debt and consumer weakness pose risks to near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →
